Forte Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Forte Capital's VRTX Position: Q2 2025 in Review
Forte Capital increased its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q2 2025, buying an estimated $62.2K and bringing the position to 12,587 shares worth $5.6M. The position accounts for 0.6% of the portfolio, ranked #40.
Forte Capital first reported a position in VRTX in Q2 2024 and has held it in 5 quarters since. The position peaked at $6.04M in Q1 2025. 1,562 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.
- Forte Capital held 12,587 shares of Vertex Pharmaceuticals worth $5.6M as of Q2 2025.
- Forte Capital bought 135 Vertex Pharmaceuticals shares in Q2 2025, an estimated $62.2K.
- Vertex Pharmaceuticals made up 0.6% of Forte Capital's portfolio in Q2 2025, its #40 holding.
- Forte Capital first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
- Forte Capital's Vertex Pharmaceuticals position peaked at $6.04M in Q1 2025.
- 1,562 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.
Based on Forte Capital's 13F filing for Q2 2025, filed 15 Jul 2025.